Glass Wealth Management’s Pfizer PFE Stock Holding History

Glass Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.59M	Buy	92,316 +2,835	+3%	+$75.5K	1%	31
2025 Q4	$2.23M	Buy	89,481 +989	+1%	+$24.9K	0.91%	34
2025 Q3	$2.25M	Buy	88,492 +3,145	+4%	+$77.6K	1.01%	32
2025 Q2	$2.07M	Sell	85,347 -1,919	-2%	-$44.8K	1.1%	33
2025 Q1	$2.21M	Sell	87,266 -17,129	-16%	-$448K	1.33%	27
2024 Q4	$2.77M	Buy	104,395 +709	+0.7%	+$19.2K	1.51%	23
2024 Q3	$3M	Buy	103,686 +3,116	+3%	+$90.9K	1.66%	21
2024 Q2	$2.81M	Buy	100,570 +1,474	+1%	+$40.6K	1.65%	26
2024 Q1	$2.75M	Buy	+99,096	New	+$2.75M	1.68%	25

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Glass Wealth Management's PFE Position: Q1 2026 in Review

Glass Wealth Management increased its Pfizer (PFE) stake by 3.2% in Q1 2026, buying an estimated $75.5K and bringing the position to 92,316 shares worth $2.59M. The position accounts for 1% of the portfolio, ranked #31.

Glass Wealth Management first reported a position in PFE in Q1 2024 and has held it in 9 quarters since. The position peaked at $3M in Q3 2024. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Glass Wealth Management held 92,316 shares of Pfizer worth $2.59M as of Q1 2026.
Glass Wealth Management bought 2,835 Pfizer shares in Q1 2026, an estimated $75.5K.
Pfizer made up 1% of Glass Wealth Management's portfolio in Q1 2026, its #31 holding.
Glass Wealth Management first reported a position in Pfizer in Q1 2024 and has held it in 9 quarters since.
Glass Wealth Management's Pfizer position peaked at $3M in Q3 2024.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Glass Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.